Literature DB >> 7277012

Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases.

M E Gombert, S H Landesman, M L Corrado, S C Stein, E T Melvin, M Cummings.   

Abstract

Three patients with Staphylococcus epidermis meningitis associated with cerebrospinal fluid (CSF) shunt devices were treated with a combination of intravenous vancomycin and oral rifampin. Two of the isolates were methicillin-resistant. All patients had a favorable clinical response. Time-kill curves showed that the addition of rifampin to vancomycin resulted in enhanced bactericidal activity against all isolates when compared to either antibiotic alone. This finding suggests that the combination of oral rifampin and intravenous vancomycin may be useful in the treatment of methicillin-resistant and recalcitrant methicillin-sensitive S. epidermis meningitis associated with CSF shunts. In vitro susceptibility testing should be performed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7277012     DOI: 10.3171/jns.1981.55.4.0633

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

Review 3.  Infections in Neurocritical Care.

Authors:  John C O'Horo; Priya Sampathkumar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

4.  Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage.

Authors:  R Bayston; C A Hart; M Barnicoat
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

5.  Production of extracellular slime by coryneforms colonizing hydrocephalus shunts.

Authors:  R Bayston; C Compton; K Richards
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

Review 6.  Chemotherapy for bacterial infections of the central nervous system.

Authors:  N M Ampel; E L Labadie
Journal:  West J Med       Date:  1987-09

7.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

8.  Intrathecal administration of netilmicin in gentamicin-resistant ventriculitis.

Authors:  E Donauer; G Drumm; J Moringlane; C Ostertag; R Kivelitz
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 9.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Reaction of rabbit lateral periventricular tissue to non-infected and infected (Staphylococcus epidermidis) shunt tubing implants. A light and transmission electron microscope study.

Authors:  Y Gedikoglu; A Colak; K Benli; T Erbengi
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.